Evensen JF - Search Results

1

Olfactory neuroblastoma: a single-center experience.

König M, Osnes T, Jebsen P, Evensen JF, Meling TR. König M, et al. Among authors: evensen jf. Neurosurg Rev. 2018 Jan;41(1):323-331. doi: 10.1007/s10143-017-0859-3. Epub 2017 May 25. Neurosurg Rev. 2018. PMID: 28540633

2

Malignant granular cell tumor of the skull base.

Meling TR, Fridrich K, Evensen JF, Nedregaard B. Meling TR, et al. Among authors: evensen jf. Skull Base. 2008 Jan;18(1):59-66. doi: 10.1055/s-2007-992763. Skull Base. 2008. PMID: 18592017 Free PMC article.

3

The influence of resection and aneuploidy on mortality in oral leukoplakia.

Sudbø J, Lippman SM, Lee JJ, Mao L, Kildal W, Sudbø A, Sagen S, Bryne M, El-Naggar A, Risberg B, Evensen JF, Reith A. Sudbø J, et al. Among authors: evensen jf. N Engl J Med. 2004 Apr 1;350(14):1405-13. doi: 10.1056/NEJMoa033374. N Engl J Med. 2004. PMID: 15070790 Free article. Retracted.

4

Combined radiotherapy and surgery in the treatment of neck node metastases from squamous cell carcinoma of the head and neck.

Boysen M, Lövdal O, Natvig K, Tausjö J, Jacobsen AB, Evensen JF. Boysen M, et al. Among authors: evensen jf. Acta Oncol. 1992;31(4):455-60. doi: 10.3109/02841869209088289. Acta Oncol. 1992. PMID: 1632982

5

Significance of self-reported symptoms as part of follow-up routines in patients treated for oral squamous cell carcinoma.

Zätterström U, Boysen M, Evensen JF. Zätterström U, et al. Among authors: evensen jf. Anticancer Res. 2014 Nov;34(11):6593-9. Anticancer Res. 2014. PMID: 25368263

6

Self-reported Symptoms to Monitor Recurrent Head and Neck Cancer-Analysis of 1,678 Cases.

Boysen ME, Zätterström UK, Evensen JF. Boysen ME, et al. Among authors: evensen jf. Anticancer Res. 2016 Jun;36(6):2849-54. Anticancer Res. 2016. PMID: 27272796

7

Value of patient-reported symptoms in the follow up of patients potentially cured of laryngeal carcinoma.

Brandstorp-Boesen J, Zätterström U, Evensen JF, Boysen M. Brandstorp-Boesen J, et al. Among authors: evensen jf. J Laryngol Otol. 2019 Jun;133(6):508-514. doi: 10.1017/S0022215119000677. Epub 2019 Apr 22. J Laryngol Otol. 2019. PMID: 31006407

8

Survival of patients with squamous cell carcinoma of the supraglottic larynx--thirty-five-year experience with radiotherapy.

Vermund H, Boysen M, Evensen JF, Jacobsen AB, Natvig K, Tausjø J, Wiley AL, Winther F. Vermund H, et al. Among authors: evensen jf. Acta Oncol. 1999;38(7):961-8. doi: 10.1080/028418699432662. Acta Oncol. 1999. PMID: 10606427

9

Associations between skin rash, treatment outcome, and single nucleotide polymorphisms in head and neck cancer patients receiving the EGFR-inhibitor zalutumumab: results from the DAHANCA 19 trial.

Brøndum L, Alsner J, Sørensen BS, Maare C, Johansen J, Primdahl H, Evensen JF, Kristensen CA, Andersen LJ, Overgaard J, Eriksen JG. Brøndum L, et al. Among authors: evensen jf. Acta Oncol. 2018 Sep;57(9):1159-1164. doi: 10.1080/0284186X.2018.1464664. Epub 2018 May 17. Acta Oncol. 2018. PMID: 29771169 Clinical Trial.

10

Prognostic factors in patients with nasopharyngeal carcinoma.

Kaasa S, Kragh-Jensen E, Bjordal K, Lund E, Evensen JF, Vermund H, Monge O, Boehler P. Kaasa S, et al. Among authors: evensen jf. Acta Oncol. 1993;32(5):531-6. doi: 10.3109/02841869309096113. Acta Oncol. 1993. PMID: 8217237

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

59 results

Search Page